Structured cost analysis of robotic TME resection for rectal cancer: a comparison between the da Vinci Si and Xi in a single surgeon's experience
- PMID: 30251144
- DOI: 10.1007/s00464-018-6465-9
Structured cost analysis of robotic TME resection for rectal cancer: a comparison between the da Vinci Si and Xi in a single surgeon's experience
Abstract
Background: Robotic-assisted surgery by the da Vinci Si appears to benefit rectal cancer surgery in selected patients, but still has some limitations, one of which is its high costs. Preliminary studies have indicated that the use of the new da Vinci Xi provides some added advantages, but their impact on cost is unknown. The aim of the present study is to compare surgical outcomes and costs of rectal cancer resection by the two platforms, in a single surgeon's experience.
Methods: From April 2010 to April 2017, 90 robotic rectal resections were performed, with either the da Vinci Si (Si-RobTME) or the da Vinci Xi (Xi-RobTME). Based on CUSUM analysis, two comparable groups of 40 consecutive Si-RobTME and 40 consecutive Xi-RobTME were obtained from the prospectively collected database and used for the present retrospective comparative study. Data costs were analysed based on the level of experience on the proficiency-gain curve (p-g curve) by the surgeon with each platform.
Results: In both groups, two homogeneous phases of the p-g curve were identified: Si1 and Xi1: cases 1-19, Si2 and Xi2: cases 20-40. A significantly higher number of full RAS operations were achieved in the Xi-RobTME group (p < 0.001). A statistically significant reduction in operating time (OT) during Si2 and Xi2 phase was observed (p < 0.001), accompanied by reduced overall variable costs (OVC), personnel costs (PC) and consumable costs (CC) (p < 0.001). All costs were lower in the Xi2 phase compared to Si2 phase: OT 265 versus 290 min (p = 0.052); OVC 7983 versus 10231.9 (p = 0.009); PC 1151.6 versus 1260.2 (p = 0.052), CC 3464.4 versus 3869.7 (p < 0.001).
Conclusions: Our experience confirms a significant reduction of costs with increasing surgeon's experience with both platforms. However, the economic gain was higher with the Xi with shorter OT, reduced PC and CC, in addition to a significantly larger number of cases performed by the fully robotic approach.
Keywords: Da Vinci Si; Da Vinci Xi; Rectal cancer; Robotic surgery; Structured costs analysis; TME.
Similar articles
-
Robot-assisted total mesorectal excision for rectal cancer: case-matched comparison of short-term surgical and functional outcomes between the da Vinci Xi and Si.Surg Endosc. 2018 Feb;32(2):589-600. doi: 10.1007/s00464-017-5708-5. Epub 2017 Jul 21. Surg Endosc. 2018. PMID: 28733738
-
Use of the new da Vinci Xi® during robotic rectal resection for cancer: a pilot matched-case comparison with the da Vinci Si®.Int J Med Robot. 2017 Mar;13(1). doi: 10.1002/rcs.1728. Epub 2016 Jan 25. Int J Med Robot. 2017. PMID: 26804716
-
Robot-assisted versus laparoscopic rectal resection for cancer in a single surgeon's experience: a cost analysis covering the initial 50 robotic cases with the da Vinci Si.Int J Colorectal Dis. 2016 Sep;31(9):1639-48. doi: 10.1007/s00384-016-2631-5. Epub 2016 Jul 31. Int J Colorectal Dis. 2016. PMID: 27475091
-
Review of Robotic Simultaneous Resection of Colorectal Cancer with Synchronous Liver Metastases Using Da Vinci Xi: Technical Considerations and Outcomes.Chirurgia (Bucur). 2023 Feb;118(1):20-26. doi: 10.21614/chirurgia.2831. Chirurgia (Bucur). 2023. PMID: 36913414 Review.
-
Optimizing outcomes of colorectal cancer surgery with robotic platforms.Surg Oncol. 2021 Jun;37:101559. doi: 10.1016/j.suronc.2021.101559. Epub 2021 Mar 31. Surg Oncol. 2021. PMID: 33839441 Review.
Cited by
-
Technical details and preliminary results of a full robotic type II endoleak treatment with the da Vinci Xi.J Robot Surg. 2019 Jun;13(3):505-509. doi: 10.1007/s11701-019-00944-z. Epub 2019 Mar 4. J Robot Surg. 2019. PMID: 30830571
-
Short-term outcomes of da Vinci Xi versus Si robotic systems for minor hepatectomies.Acta Biomed. 2022 Oct 26;93(5):e2022223. doi: 10.23750/abm.v93i5.12851. Acta Biomed. 2022. PMID: 36300236 Free PMC article.
-
A comparison of the da Vinci Xi vs. da Vinci Si surgical systems for radical prostatectomy.BMC Surg. 2021 Nov 30;21(1):409. doi: 10.1186/s12893-021-01406-w. BMC Surg. 2021. PMID: 34847882 Free PMC article.
-
Prospective multicentre observational cohort to assess quality of life, functional outcomes and cost-effectiveness following minimally invasive surgical techniques for rectal cancer in 'dedicated centres' in the Netherlands (VANTAGE trial): a protocol.BMJ Open. 2022 Aug 19;12(8):e057640. doi: 10.1136/bmjopen-2021-057640. BMJ Open. 2022. PMID: 35985776 Free PMC article.
-
The use of robot-assisted surgery for visceral abdominal aneurysms treatment.J Robot Surg. 2021 Feb;15(1):153-154. doi: 10.1007/s11701-020-01122-2. Epub 2020 Sep 9. J Robot Surg. 2021. PMID: 32909109 No abstract available.
References
-
- Luca F, Valvo M, Ghezzi TL, Zuccaro M, Cenciarelli S, Trovato C, Sonzogni A, Biffi R (2013) Impact of robotic surgery on sexual and urinary functions after fully robotic nerve-sparing total mesorectal excision for rectal cancer. Ann Surg 257:672–678. https://doi.org/10.1097/SLA.0b013e318269d03b - DOI - PubMed
-
- D’Annibale A, Morpurgo E, Fiscon V, Trevisan P, Sovernigo G, Orsini C, Guidolin D (2004) Robotic and laparoscopic surgery for treatment of colorectal diseases. Dis Colon Rectum 47:2162–2168. https://doi.org/10.1007/s10350-004-0711-z - DOI - PubMed
-
- D’Annibale A, Pernazza G, Monsellato I, Pende V, Lucandri G, Mazzocchi P, Alfano G (2013) Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc 27:1887–1895. https://doi.org/10.1007/s00464-012-2731-4 - DOI - PubMed
-
- Morelli L, Ceccarelli C, Di Franco G, Guadagni S, Palmeri M, Caprili G, D’Isidoro C, Marciano E, Pollina L, Campani D, Massimetti G, Di Candio G, Mosca F (2016) Sexual and urinary functions after robot-assisted versus pure laparoscopic total mesorectal excision for rectal cancer. Int J Colorectal Dis 31:913–915. https://doi.org/10.1007/s00384-015-2301-z - DOI - PubMed
-
- Delacroix SE, Winters JC (2010) Voiding dysfunction after pelvic colorectal surgery. Clin Colon Rectal Surg 23:119–127. https://doi.org/10.1055/s-0030-1254299 - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous